tetano
Editor, Senior Moderator
Blood Sci
. 2022 Oct;4(4):192-198.
doi: 10.1097/BS9.0000000000000132. Epub 2022 Aug 1.
Immune checkpoint alterations and their blockade in COVID-19 patients
Jiaxiong Tan[SUP] 1 [/SUP], Yangqiu Li[SUP] 2 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that seriously affects people's lives. Immune dysfunction, which is characterized by abnormal expression of multiple immune checkpoint proteins (ICs) on immune cells, is associated with progression and poor prognosis for tumors and chronic infections. Immunotherapy targeting ICs has been well established in modulating immune function and improving clinical outcome for solid tumors and hematological malignancies. The role of ICs in different populations or COVID-19 stages and the impact of IC blockade remains unclear. In this review, we summarized current studies of alterations in ICs in COVID-19 to better understand immune changes and provide strategies for treating COVID-19 patients, particularly those with cancer.
. 2022 Oct;4(4):192-198.
doi: 10.1097/BS9.0000000000000132. Epub 2022 Aug 1.
Immune checkpoint alterations and their blockade in COVID-19 patients
Jiaxiong Tan[SUP] 1 [/SUP], Yangqiu Li[SUP] 2 [/SUP]
Affiliations
- PMID: 36311817
- PMCID: PMC9592141
- DOI: 10.1097/BS9.0000000000000132
Abstract
Coronavirus disease 2019 (COVID-19) is a highly contagious disease that seriously affects people's lives. Immune dysfunction, which is characterized by abnormal expression of multiple immune checkpoint proteins (ICs) on immune cells, is associated with progression and poor prognosis for tumors and chronic infections. Immunotherapy targeting ICs has been well established in modulating immune function and improving clinical outcome for solid tumors and hematological malignancies. The role of ICs in different populations or COVID-19 stages and the impact of IC blockade remains unclear. In this review, we summarized current studies of alterations in ICs in COVID-19 to better understand immune changes and provide strategies for treating COVID-19 patients, particularly those with cancer.